4.3 Editorial Material

Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer

Journal

JOURNAL OF THORACIC DISEASE
Volume 10, Issue -, Pages S3186-S3191

Publisher

AME PUBLISHING COMPANY
DOI: 10.21037/jtd.2018.08.25

Keywords

-

Funding

  1. Novel Treatment Strategies for Adenocarcinomas (UCD) [49873]
  2. Shanghai Jiaotong University Affiliated Sixth People's Hospital

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available